<div id="readability-page-1">01:43 PM EDT, 05/14/2026 (MT Newswires) -- Healthcare stocks edged down Thursday afternoon, with the NYSE Healthcare Index easing 0.1% and the State Street Healthcare Select Sector SPDR ETF (XLV) fractionally lower.The iShares Biotechnology ETF (IBB) decreased 0.5%.In corporate news, Biogen (BIIB) shares fell nearly 6% after the firm said Thursday that a phase 2 trial of diranersen in people with early Alzheimer's disease did not meet its primary endpoint.Prestige Consumer Healthcare ( PBH ) reported weaker-than-expected Q4 results and issued 2026 guidance below consensus, with the shortfall driven primarily by supply constraints in Clear Eyes and broader execution pressures, Oppenheimer said in a note. Oppenheimer downgraded the stock to perform from outperform and removed its $65 price target. Prestige shares slumped past 8%.Doximity ( DOCS ) could face near-term pressure from slowing growth after issuing weaker-than-expected guidance, though strong user engagement trends and expanding AI opportunities continue to support the stock's long-term outlook, Morgan Stanley said in a note. Morgan Stanley lowered the price target on Doximity ( DOCS ) to $35 from $49, while maintaining an overweight rating. Doximity ( DOCS ) shares dropped more than 24%.Aveanna Healthcare ( AVAH ) shares jumped 11% after it reported higher fiscal Q1 adjusted earnings and revenue, and raised its fiscal 2026 revenue guidance. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

AVAH

BIIB

DOCS

Healthcare stocks declined on Thursday, with the NYSE Healthcare Index down 0.1%. Biogen shares fell nearly 6% after a failed Alzheimer's trial. Prestige Consumer Healthcare reported disappointing Q4 results and lowered 2026 guidance, leading to an 8% drop in shares. Doximity's shares dropped over 24% after issuing weak guidance, despite long-term growth potential. In contrast, Aveanna Healthcare shares rose 11% following strong Q1 earnings and an increased revenue forecast for 2026.

Fidelity

Aveanna Healthcare

Biogen

Doximity

Prestige Brands

Langar Global HealthTech ETF

SPDR S&P Biotech

iShares US Healthcare Providers

iShares US Healthcare

SPDR S&P Health Equip

VG Health

iShares US Pharma

VanEck Biotech ETF

Invesco Nasdaq Biotechnology ETF

iShares Global Healthcare

Direxion S&P Biotech Bull 3X

iShares Genomics Immunology and Healthcare ETF

iShares US Medical Devices

First Trust NYSE Arca Biotech Index Fd

Invesco Biotechnology & Genome ETF

iShares Biotechnology ETF

SPDR S&P Health

Ark Genomic Revolution ETF

Global X HealthTech ETF

ALPS Medical Breakthrough

Health Care Select Sector SPDR

Proshares Ultra Nasdaq Biotech

Sector Update: Healthcare Stocks Softer Thursday Afternoon